Literature DB >> 27411488

Differences in prognosis of stereotyped IGHV3-21 chronic lymphocytic leukaemia according to additional molecular and cytogenetic aberrations.

S Jeromin1, C Haferlach1, F Dicker1, T Alpermann1, T Haferlach1, W Kern1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27411488     DOI： 10.1038/leu.2016.189

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.

Authors:  Emanuela M Ghia; Sonia Jain; George F Widhopf; Laura Z Rassenti; Michael J Keating; William G Wierda; John G Gribben; Jennifer R Brown; Kanti R Rai; John C Byrd; Neil E Kay; Andrew W Greaves; Thomas J Kipps
Journal:  Blood       Date:  2008-03-07       Impact factor: 22.113

2.  Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia.

Authors:  Wolfgang Kern; Frank Dicker; Susanne Schnittger; Claudia Haferlach; Torsten Haferlach
Journal:  Cytometry B Clin Cytom       Date:  2009-11       Impact factor: 3.058

3.  Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.

Authors:  C Haferlach; F Dicker; S Schnittger; W Kern; T Haferlach
Journal:  Leukemia       Date:  2007-09-06       Impact factor: 11.528

4.  Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.

Authors:  Panagiotis Baliakas; Andreas Agathangelidis; Anastasia Hadzidimitriou; Lesley-Ann Sutton; Eva Minga; Athina Tsanousa; Lydia Scarfò; Zadie Davis; Xiao-Jie Yan; Tait Shanafelt; Karla Plevova; Yorick Sandberg; Fie Juhl Vojdeman; Myriam Boudjogra; Tatiana Tzenou; Maria Chatzouli; Charles C Chu; Silvio Veronese; Anne Gardiner; Larry Mansouri; Karin E Smedby; Lone Bredo Pedersen; Denis Moreno; Kirsten Van Lom; Véronique Giudicelli; Hana Skuhrova Francova; Florence Nguyen-Khac; Panagiotis Panagiotidis; Gunnar Juliusson; Lefteris Angelis; Achilles Anagnostopoulos; Marie-Paule Lefranc; Monica Facco; Livio Trentin; Mark Catherwood; Marco Montillo; Christian H Geisler; Anton W Langerak; Sarka Pospisilova; Nicholas Chiorazzi; David Oscier; Diane F Jelinek; Nikos Darzentas; Chrysoula Belessi; Frederic Davi; Paolo Ghia; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood       Date:  2014-12-17       Impact factor: 22.113

5.  Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Valeria Spina; Riccardo Bomben; Silvia Rasi; Michele Dal-Bo; Alessio Bruscaggin; Francesca Maria Rossi; Sara Monti; Massimo Degan; Carmela Ciardullo; Roberto Serra; Antonella Zucchetto; Josep Nomdedeu; Pietro Bulian; Alberto Grossi; Francesco Zaja; Gabriele Pozzato; Luca Laurenti; Dimitar G Efremov; Francesco Di-Raimondo; Roberto Marasca; Francesco Forconi; Giovanni Del Poeta; Gianluca Gaidano; Valter Gattei
Journal:  Blood       Date:  2013-05-01       Impact factor: 22.113

6.  Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies.

Authors:  Andreas Agathangelidis; Nikos Darzentas; Anastasia Hadzidimitriou; Xavier Brochet; Fiona Murray; Xiao-Jie Yan; Zadie Davis; Ellen J van Gastel-Mol; Cristina Tresoldi; Charles C Chu; Nicola Cahill; Veronique Giudicelli; Boris Tichy; Lone Bredo Pedersen; Letizia Foroni; Lisa Bonello; Agnieszka Janus; Karin Smedby; Achilles Anagnostopoulos; Helene Merle-Beral; Nikolaos Laoutaris; Gunnar Juliusson; Paola Francia di Celle; Sarka Pospisilova; Jesper Jurlander; Christian Geisler; Athanasios Tsaftaris; Marie-Paule Lefranc; Anton W Langerak; David Graham Oscier; Nicholas Chiorazzi; Chrysoula Belessi; Frederic Davi; Richard Rosenquist; Paolo Ghia; Kostas Stamatopoulos
Journal:  Blood       Date:  2012-03-13       Impact factor: 22.113

7.  Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

Authors:  Gerard Tobin; Ulf Thunberg; Anna Johnson; Inger Eriksson; Ola Söderberg; Karin Karlsson; Mats Merup; Gunnar Juliusson; Juhani Vilpo; Gunilla Enblad; Christer Sundström; Göran Roos; Richard Rosenquist
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

8.  Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status.

Authors:  Mia Thorsélius; Alexander Kröber; Fiona Murray; Ulf Thunberg; Gerard Tobin; Andreas Bühler; Dirk Kienle; Emilia Albesiano; Rossana Maffei; Lan-Phuong Dao-Ung; James Wiley; Juhani Vilpo; Anna Laurell; Mats Merup; Göran Roos; Karin Karlsson; Nicholas Chiorazzi; Roberto Marasca; Hartmut Döhner; Stephan Stilgenbauer; Richard Rosenquist
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

9.  Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.

Authors:  Panagiotis Baliakas; Anastasia Hadzidimitriou; Lesley-Ann Sutton; Eva Minga; Andreas Agathangelidis; Michele Nichelatti; Athina Tsanousa; Lydia Scarfò; Zadie Davis; Xiao-Jie Yan; Tait Shanafelt; Karla Plevova; Yorick Sandberg; Fie Juhl Vojdeman; Myriam Boudjogra; Tatiana Tzenou; Maria Chatzouli; Charles C Chu; Silvio Veronese; Anne Gardiner; Larry Mansouri; Karin E Smedby; Lone Bredo Pedersen; Kirsten van Lom; Véronique Giudicelli; Hana Skuhrova Francova; Florence Nguyen-Khac; Panagiotis Panagiotidis; Gunnar Juliusson; Lefteris Angelis; Achilles Anagnostopoulos; Marie-Paule Lefranc; Monica Facco; Livio Trentin; Mark Catherwood; Marco Montillo; Christian H Geisler; Anton W Langerak; Sarka Pospisilova; Nicholas Chiorazzi; David Oscier; Diane F Jelinek; Nikos Darzentas; Chrysoula Belessi; Frederic Davi; Richard Rosenquist; Paolo Ghia; Kostas Stamatopoulos
Journal:  Lancet Haematol       Date:  2014-11-03       Impact factor: 18.959

10.  ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy.

Authors:  Vojtech Bystry; Andreas Agathangelidis; Vasilis Bikos; Lesley Ann Sutton; Panagiotis Baliakas; Anastasia Hadzidimitriou; Kostas Stamatopoulos; Nikos Darzentas
Journal:  Bioinformatics       Date:  2015-08-06       Impact factor: 6.937
View more
  4 in total

1.  Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification.

Authors:  Lesley-Ann Sutton; Anastasia Hadzidimitriou; Panagiotis Baliakas; Andreas Agathangelidis; Anton W Langerak; Stephan Stilgenbauer; Sarka Pospisilova; Zadie Davis; Francesco Forconi; Frederic Davi; Paolo Ghia; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2017-06       Impact factor: 9.941

2.  No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.

Authors:  Panagiotis Baliakas; Mattias Mattsson; Anastasia Hadzidimitriou; Eva Minga; Andreas Agathangelidis; Lesley-Ann Sutton; Lydia Scarfo; Zadie Davis; Xiao-Jie Yan; Karla Plevova; Yorick Sandberg; Fie J Vojdeman; Tatiana Tzenou; Charles C Chu; Silvio Veronese; Larry Mansouri; Karin E Smedby; Véronique Giudicelli; Florence Nguyen-Khac; Panagiotis Panagiotidis; Gunnar Juliusson; Achilles Anagnostopoulos; Marie-Paule Lefranc; Livio Trentin; Mark Catherwood; Marco Montillo; Carsten U Niemann; Anton W Langerak; Sarka Pospisilova; Niki Stavroyianni; Nicholas Chiorazzi; David Oscier; Diane F Jelinek; Tait Shanafelt; Nikos Darzentas; Chrysoula Belessi; Frederic Davi; Paolo Ghia; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2017-12-21       Impact factor: 9.941

3.  Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).

Authors:  Sonia Jaramillo; Andreas Agathangelidis; Christof Schneider; Jasmin Bahlo; Sandra Robrecht; Eugen Tausch; Johannes Bloehdorn; Manuela Hoechstetter; Kirsten Fischer; Barbara Eichhorst; Valentin Goede; Michael Hallek; Hartmut Döhner; Richard Rosenquist; Paolo Ghia; Kostas Stamatopoulos; Stephan Stilgenbauer
Journal:  Haematologica       Date:  2019-12-26       Impact factor: 9.941

4.  Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.

Authors:  Panagiotis Baliakas; Theodoros Moysiadis; Anastasia Hadzidimitriou; Aliki Xochelli; Sabine Jeromin; Andreas Agathangelidis; Mattias Mattsson; Lesley-Ann Sutton; Eva Minga; Lydia Scarfò; Davide Rossi; Zadie Davis; Neus Villamor; Helen Parker; Jana Kotaskova; Evangelia Stalika; Karla Plevova; Larry Mansouri; Diego Cortese; Alba Navarro; Julio Delgado; Marta Larrayoz; Emma Young; Achilles Anagnostopoulos; Karin E Smedby; Gunnar Juliusson; Oonagh Sheehy; Mark Catherwood; Jonathan C Strefford; Niki Stavroyianni; Chrysoula Belessi; Sarka Pospisilova; David Oscier; Gianluca Gaidano; Elias Campo; Claudia Haferlach; Paolo Ghia; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2018-09-27       Impact factor: 9.941
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.